Share Price | Sarda Proteins Ltd Stock Analysis & Recommendation

Q: Why is Sarda Proteins Ltd falling/rising?

As of 09-Jun, Sarda Proteins Ltd's stock price is currently stable at Rs 93.13, showing no change (0.00%). However, the stock has demonstrated a positive performance trend over various periods, which indicates a rising tendency in the stock price. Over the past week, the stock has increased by 4.99%, while it has risen by 10.24% over the last month. Year-to-date, the stock has gained 25.66%, significantly outperforming the Sensex, which has declined by 13.26% during the same period.Today's trading activity reflects a strong performance, as the stock opened with a gain of 4.99% and reached an intraday high of Rs 93.13. Additionally, Sarda Proteins is trading above its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which is a positive indicator of its price momentum.Despite these positive trends, there are signs of erratic trading, as the stock did not trade on 4 out of the last 20 days, and there has been a significant drop in investor participation, with delivery volume falling by 96.65% against the 5-day average. This decline in participation could be a concern for future price movements.Overall, while the stock is currently stable, the recent upward trends and performance against benchmarks suggest that Sarda Proteins Ltd is experiencing a rising trajectory in its stock price, despite some underlying issues with trading consistency and investor engagement.

Q: Should I buy, sell or hold Sarda Proteins Ltd?

Based on the current financial situation of Sarda Proteins Ltd, it is advisable to consider a strong sell position. The company has demonstrated weak long-term fundamental strength, with a significant decline in operating profits at a -21.93% CAGR over the past five years. Additionally, the company's ability to service its debt is concerning, highlighted by a poor EBIT to Interest ratio of -0.02. The return on equity is also low at an average of 3.91%, indicating limited profitability relative to shareholders' funds. Recent results show a drastic drop in net sales, with a -78.50% growth over the last nine months, further emphasizing the company's struggles. Moreover, the negative EBITDA of Rs. -0.42 crore and a 56% decline in profits over the past year add to the risk associated with this stock, which is trading at risky levels compared to its historical valuations. With the majority of shareholders being non-institutional, this may also affect the stock's stability and investor confidence.Given these factors, it would be prudent to sell or avoid investing in Sarda Proteins Ltd at this time.

Q: When is the next results date for Sarda Proteins Ltd?

The next results date for Sarda Proteins Ltd is scheduled for April 30, 2026.

Q: How has been the historical performance of Sarda Proteins?

Answer:The historical performance of Sarda Proteins shows significant fluctuations in its financial metrics over the years.Breakdown:Sarda Proteins experienced a notable increase in net sales, rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, following a trend of varying sales figures over the previous years. The total operating income also reflected this growth, reaching 24.19 Cr in Mar'25 compared to 1.30 Cr in the prior year. However, the company faced challenges with total expenditure, which increased to 24.17 Cr in Mar'25 from 1.44 Cr in Mar'24. This resulted in a marginal operating profit of 0.02 Cr in Mar'25, a slight improvement from the losses recorded in earlier years. The profit before tax remained stable at 0.02 Cr for both Mar'25 and Mar'24, while profit after tax showed a decrease to 0.01 Cr in Mar'25 from 0.02 Cr in Mar'24. The earnings per share (EPS) also reflected this trend, decreasing to 0.06 in Mar'25 from 0.12 in Mar'24. On the balance sheet, total assets increased to 2.53 Cr in Mar'25 from 2.30 Cr in Mar'24, driven by a rise in short-term loans and advances. Overall, while Sarda Proteins has shown growth in sales and total assets, profitability metrics indicate ongoing challenges.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

7.73 k (400.00%) Volume

Shareholding (Apr 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

0.00%

Why is Sarda Proteins Ltd falling/rising?

10-Jun-2026

As of 09-Jun, Sarda Proteins Ltd's stock price is stable at Rs 93.13, with a positive trend showing a 25.66% year-to-date gain, outperforming the Sensex. However, there are concerns about erratic trading and a significant drop in investor participation.

View full answer

Which are the latest news on Sarda Proteins?

10-Jun-2026

Sarda Proteins Ltd is Rated Strong Sell
Sarda Proteins Ltd is Rated Strong Sell

Should I buy, sell or hold Sarda Proteins Ltd?

01-May-2026

When is the next results date for Sarda Proteins Ltd?

29-Apr-2026

The next results date for Sarda Proteins Ltd is April 30, 2026.

View full answer

How has been the historical performance of Sarda Proteins?

01-Dec-2025

Sarda Proteins has shown significant sales growth, with net sales rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, but faced challenges with increased expenditures, resulting in marginal operating profit and a decrease in profit after tax and EPS. Overall, while sales and total assets have grown, profitability remains a concern.

View full answer

Is Sarda Proteins overvalued or undervalued?

09-Jun-2025

As of January 6, 2025, Sarda Proteins Ltd. is considered overvalued with a "risky" rating due to high financial ratios, including a PE Ratio of 22.60 and a Price to Book Value of 9.54, despite a strong 1-year return of 62.51%.

View full answer

What is the technical trend for Sarda Proteins?

09-Jun-2025

As of May 20, 2025, Sarda Proteins shows a mildly bullish trend with mixed signals from indicators like the MACD, Bollinger Bands, and RSI, suggesting caution despite the current price being at a 52-week high of 137.45.

View full answer

Compare Sarda Proteins with Similar Stocks

Prime Industries Raj Oil Mills Ambar Protein

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.20%

Poor long term growth as Net Sales has grown by an annual rate of 4.87% and Operating profit at 2.29% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.07

With ROE of 20.9, it has a Very Expensive valuation with a 27.8 Price to Book Value

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Edible Oil

Market cap

INR 84 Cr (Micro Cap)

P/E

133.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-2.44

Return on Equity

20.93%

Price to Book

26.45

Revenue and Profits:

Net Sales:

1 Cr

(Quarterly Results - Mar 2026)

Net Profit:

1 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

35.32%

6 Months

24.49%

1 Year

-32.24%

2 Years

4.88%

3 Years

92.34%

4 Years

210.43%

5 Years

182.21%

Sarda Proteins for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Sarda Proteins Ltd is Rated Strong Sell

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sarda Proteins Ltd is Rated Strong Sell

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sarda Proteins Ltd Valuation Shifts Signal Heightened Risk Amid Strong Sell Rating

Sarda Proteins Ltd, a micro-cap player in the edible oil sector, has witnessed a significant shift in its valuation parameters, prompting a reassessment of its price attractiveness. Despite a robust five-year return of 350.56%, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged to levels that challenge traditional valuation norms, raising concerns among investors and analysts alike.

Read full news article

Announcements

Recommendations of Committee of Independent Directors (IDC)

08-Jun-2026 | Source : BSE

Independent Directors Committee (IDC) have submitted to BSE recommendations under Regulation 26(7) of SEBI (SAST) Regulations 2011 for the Open Offer to Public Shareholders of Sarda Proteins Ltd (Target Company)

Letter of Offer

04-Jun-2026 | Source : BSE

Grow House Wealth Management Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Letter of Offer to the Public Shareholders of the Sarda Proteins Ltd (Target Company).

Non Applicability Of Annual Secretarial Complliance Report For The Year Ended 31.03.2026

03-Jun-2026 | Source : BSE

Non Applicability of Annual Secretarial Compliance Report for the year ended 31.03.2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.87%

EBIT Growth (5y)

2.29%

EBIT to Interest (avg)

0.07

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-2.44

Sales to Capital Employed (avg)

5.16

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-2.02%

ROE (avg)

8.81%

Valuation key factors

Factor

Value

P/E Ratio

133

Industry P/E

Price to Book Value

27.77

EV to EBIT

76.24

EV to EBITDA

76.24

EV to Capital Employed

-17.57

EV to Sales

4.72

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

20.93%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Apr 2026

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ritika Vegetable Oil Private Limited (0.0%)

Highest Public shareholder

Onix Renewable Limited (77.99%)

Individual Investors Holdings

20.31%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 160.00% vs -94.19% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 800.00% vs -130.00% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.65",
          "val2": "0.25",
          "chgp": "160.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.60",
          "val2": "-0.12",
          "chgp": "600.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.84",
          "val2": "-0.12",
          "chgp": "800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.31%",
          "val2": "-48.00%",
          "chgp": "140.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 10,800.00% vs -41.67% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -400.00% vs 400.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.26",
          "val2": "0.14",
          "chgp": "10,800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.19",
          "val2": "0.02",
          "chgp": "-1,050.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.09",
          "val2": "0.03",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.25%",
          "val2": "14.29%",
          "chgp": "-15.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -35.88% vs 1,850.81% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -261.54% vs 0.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.51",
          "val2": "24.19",
          "chgp": "-35.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.31",
          "val2": "0.12",
          "chgp": "-358.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.21",
          "val2": "0.13",
          "chgp": "-261.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.00%",
          "val2": "0.50%",
          "chgp": "-2.50%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -33.20% vs 1,760.77% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 6,300.00% vs -50.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.16",
          "val2": "24.19",
          "chgp": "-33.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.29",
          "val2": "0.02",
          "chgp": "1,350.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.64",
          "val2": "0.01",
          "chgp": "6,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.79%",
          "val2": "0.08%",
          "chgp": "1.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

0.65

0.25

160.00%

Operating Profit (PBDIT) excl Other Income

0.60

-0.12

600.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.84

-0.12

800.00%

Operating Profit Margin (Excl OI)

92.31%

-48.00%

140.31%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 160.00% vs -94.19% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 800.00% vs -130.00% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

15.26

0.14

10,800.00%

Operating Profit (PBDIT) excl Other Income

-0.19

0.02

-1,050.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.09

0.03

-400.00%

Operating Profit Margin (Excl OI)

-1.25%

14.29%

-15.54%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is 10,800.00% vs -41.67% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is -400.00% vs 400.00% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

15.51

24.19

-35.88%

Operating Profit (PBDIT) excl Other Income

-0.31

0.12

-358.33%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.21

0.13

-261.54%

Operating Profit Margin (Excl OI)

-2.00%

0.50%

-2.50%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2025 is -35.88% vs 1,850.81% in Dec 2024

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -261.54% vs 0.00% in Dec 2024

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

16.16

24.19

-33.20%

Operating Profit (PBDIT) excl Other Income

0.29

0.02

1,350.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.64

0.01

6,300.00%

Operating Profit Margin (Excl OI)

1.79%

0.08%

1.71%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -33.20% vs 1,760.77% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 6,300.00% vs -50.00% in Mar 2025

All Annual Results

Company CV

About Sarda Proteins Ltd

Sarda Proteins Ltd

Micro Cap

Edible Oil

Sarda Proteins Limited was incorporated on December 03, 1991. The Company is mainly engaged in trading of Edible Oils and Agri Commodities, which includes wheat, Oil Seeds, Grains, Edible Oil, etc. The management of the Company was duly changed in FY 2018-19, pursuant to completion of acquisition process by Ritika Vegetable Oil Private Limited as per Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Company Coordinates

Company Details

B-536-537, Matsya Industrial Area Alwar Rajasthan : 301030

Tel: 91-144-2881392

http://www.sardaproteins.com

sardaproteins@yahoo.com

Registrar Details

Link Intime India Pvt Ltd., Narang Tower 44, Community Centre, Naraina Industrial Area , Phase - 1, New Delhi